Barrett's esophagus: Emerging knowledge and management strategies

Pathology Research International

Volumn 2012, Issue , 2012, Pages

  Bhardwaj, Atul ^a   McGarrity, Thomas J ^a   Stairs, Douglas B ^a   Mani, Haresh ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866254116     PISSN: None     EISSN: 2042003X     Source Type: Journal    
DOI: 10.1155/2012/814146     Document Type: Review

References (201)

1. Steevens J., Botterweck A. A. M., Dirx M. J. M., Van Den Brandt P. A., Schouten L. J., Trends in incidence of oesophageal and stomach cancer subtypes in Europe. European Journal of Gastroenterology and Hepatology 2010 22 6 669 678 2-s2.0-77951689504 10.1097/MEG.0b013e32832ca091
2. Cook M. B., Chow W. H., Devesa S. S., Oesophageal cancer incidence in the United States by race, sex, and histologic type, 19772005. British Journal of Cancer 2009 101 5 855 859 2-s2.0-70249118103 10.1038/sj.bjc.6605246
3. Yousef F., Cardwell C., Cantwell M. M., Galway K., Johnston B. T., Murray L., The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. American Journal of Epidemiology 2008 168 3 237 249 2-s2.0-47649099118 10.1093/aje/kwn121 (Pubitemid 352019777)
4. Pohl H., Welch H. G., The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. Journal of the National Cancer Institute 2005 97 2 142 146 2-s2.0-13744258445 10.1093/jnci/dji024 (Pubitemid 40277094)
5. Eloubeidi M. A., Mason A. C., Desmond R. A., El-Serag H. B., Temporal trends (19731997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? American Journal of Gastroenterology 2003 98 7 1627 1633 2-s2.0-0038457443 (Pubitemid 36875359)
6. Lagergren J., Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut 2005 54 supplement 1 i1 i5 2-s2.0-14344249865 10.1136/gut.2004.041517 (Pubitemid 40293002)
7. Bhat S., Coleman H. G., Yousef F., Johnston B. T., McManus D. T., Gavin A. T., Murray L. J., Risk of malignant progression in Barrett's Esophagus patients: results from a large population-based study. Journal of the National Cancer Institute 2011 103 13 1049 1057 2-s2.0-79960249713 10.1093/jnci/djr203
8. Spechler S. J., Sharma P., Souza R. F., Inadomi J. M., Shaheen N. J., American gastroenterological association technical review on the management of Barrett's esophagus. Gastroenterology 2011 140 3 e18 e52 2-s2.0-79952305740 10.1053/j.gastro.2011.01.031
9. Playford R. J., New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus. Gut 2006 55 4 442 443 2-s2.0-33645131562 10.1136/gut.2005.083600
10. Riddell R. H., Odze R. D., Definition of barrett's esophagus: time for a rethinkis intestinal metaplasia dead. American Journal of Gastroenterology 2009 104 10 2588 2594 2-s2.0-70350491200 10.1038/ajg.2009.390
11. Gerson L. B., Shetler K., Triadafilopoulos G., Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002 123 2 461 467 2-s2.0-0036320158 10.1053/gast.2002.34748 (Pubitemid 34827190)
12. Rex D. K., Cummings O. W., Shaw M., Cumings M. D., Wong R. K. H., Vasudeva R. S., Dunne D., Rahmani E. Y., Helper D. J., Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003 125 6 1670 1677 2-s2.0-0344628832 10.1053/j.gastro.2003.09.030 (Pubitemid 37500431)
13. Ronkainen J., Aro P., Storskrubb T., Johansson S. E., Lind T., Bolling-Sternevald E., Vieth M., Stolte M., Talley N. J., Agréus L., Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005 129 6 1825 1831 2-s2.0-28844461009 10.1053/j.gastro.2005.08.053 (Pubitemid 41772961)
14. Hvid-Jensen F., Pedersen L., Drewes A. M., Sorensen H. T., Funch-Jensen P., Incidence of adenocarcinoma among patients with Barrett's esophagus. The New England Journal of Medicine 2011 365 15 1375 1383
15. Moyes L. H., Going J. J., Still waiting for predictive biomarkers in Barrett's oesophagus. Journal of Clinical Pathology 2011 64 9 742 750 2-s2.0-79956191494 10.1136/jclinpath-2011-200084
16. Sharma P., Dent J., Armstrong D., Bergman J. J. G. H. M., Gossner L., Hoshihara Y., Jankowski J. A., Junghard O., Lundell L., Tytgat G. N. J., Vieth M., The development and validation of an endoscopic grading system for Barrett's esophagus: the prague C & M criteria. Gastroenterology 2006 131 5 1392 1399 2-s2.0-33750720001 10.1053/j.gastro.2006.08.032 (Pubitemid 44708937)
17. Barrett N. R., Chronic peptic ulcer of the oesophagus and 'oesophagitis'. The British Journal of Surgery 1950 38 150 175 182 2-s2.0-76549218484
18. Allison P. R., Johnstone A. S., The oesophagus lined with gastric mucous membrane. Thorax 1953 8 2 87 101 2-s2.0-0002067043
19. Barrett N. R., The lower esophagus lined by columnar epithelium. Surgery 1957 41 6 881 894 2-s2.0-0000051338
20. Spechler S. J., Goyal R. K., The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996 110 2 614 621 2-s2.0-0030040665 (Pubitemid 26043897)
21. Wang K. K., Sampliner R. E., Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. American Journal of Gastroenterology 2008 103 3 788 797 2-s2.0-40949156279 10.1111/j.1572-0241.2008. 01835.x (Pubitemid 351406009)
22. McClave S. A., Boyce H. W., Gottfried M. R., Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion. Gastrointestinal Endoscopy 1987 33 6 413 416 2-s2.0-0023555004 (Pubitemid 18018923)
23. Choi D. W., Oh S. N., Baek S. J., Ahn S. H., Chang Y. J., Jeong W. S., Kim H. J., Yeon J. E., Park J. J., Kim J. S., Byun K. S., Bak Y. T., Lee C. H., Endoscopically observed lower esophageal capillary patterns. The Korean Journal of Internal Medicine 2002 17 4 245 248 2-s2.0-0036986668
24. Vianna A., Hayes P. C., Moscoso G., Driver M., Portmann B., Westaby D., Williams R., Normal venous circulation of the gastroesophageal junction: a route to understanding varices. Gastroenterology 1987 93 4 876 889 2-s2.0-0023242355 (Pubitemid 17156016)
25. Paull A., Trier J. S., Dalton M. D., The histologic spectrum of Barrett's esophagus. New England Journal of Medicine 1976 295 9 476 480 2-s2.0-0017118735
26. Hirota W. K., Loughney T. M., Lazas D. J., Maydonovitch C. L., Rholl V., Wong R. K. H., Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999 116 2 277 285 2-s2.0-0032958704 10.1016/S0016-5085(99) 70123-X (Pubitemid 29055349)
27. Peck-Radosavljevic M., Puspok A., Potzi R., Oberhuber G., Histological findings after routine biopsy at the gastro-oesophageal junction. European Journal of Gastroenterology & Hepatology 1999 11 11 1265 1270 (Pubitemid 29531349)
28. Spechler S. J., Intestinal metaplasia at the gastroesophageal junction. Gastroenterology 2004 126 2 567 575 2-s2.0-0842343423 10.1053/j.gastro.2003.11. 061 (Pubitemid 38182313)
29. Thomas T., Abrams K. R., De Caestecker J. S., Robinson R. J., Meta analysis: cancer risk in Barrett's oesophagus. Alimentary Pharmacology and Therapeutics 2007 26 11-12 1465 1477 2-s2.0-36549033910 10.1111/j.1365-2036. 2007.03528.x (Pubitemid 350178802)
30. Liu W., Hahn H., Odze R. D., Goyal R. K., Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium. American Journal of Gastroenterology 2009 104 4 816 824 2-s2.0-65449135220 10.1038/ajg.2009.85
31. Hahn H. P., Blount P. L., Ayub K., Das K. M., Souza R., Spechler S., Odze R. D., Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus. American Journal of Surgical Pathology 2009 33 7 1006 1015 2-s2.0-67649538054 10.1097/PAS.0b013e31819f57e9
32. Öberg S., Johansson J., Wenner J., Johnsson F., Zilling T., Staël Von Holstein C., Nilsson J., Walther B., Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery. Annals of Surgery 2001 234 5 619 626 2-s2.0-0034760432 10.1097/00000658-200111000-00006 (Pubitemid 33041764)
33. Jones T. F., Sharma P., Daaboul B., Cherian R., Mayo M., Topalovski M., Weston A. P., Yield of intestinal metaplasia in patients with suspected short-segment Barrett's esophagus (SSBE) on repeat endoscopy. Digestive Diseases and Sciences 2002 47 9 2108 2111 2-s2.0-0036714147 10.1023/A:1019697501650 (Pubitemid 35024831)
34. Harrison R., Perry I., Haddadin W., McDonald S., Bryan R., Abrams K., Sampliner R., Talley N. J., Moayyedi P., Jankowski J. A., Detection of intestinal metaplasia in Barrett's Esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. American Journal of Gastroenterology 2007 102 6 1154 1161 2-s2.0-34249086543 10.1111/j.1572-0241. 2007.01230.x (Pubitemid 46802035)
35. Crockett S. D., Lippmann Q. K., Dellon E. S., Shaheen N. J., Health-related quality of life in patients with Barrett's esophagus: a systematic review. Clinical Gastroenterology and Hepatology 2009 7 6 613 623 2-s2.0-66149181765 10.1016/j.cgh.2009.02.024
36. Shaheen N. J., Green B., Medapalli R. K., Mitchell K. L., Wei J. T., Schmitz S. M., West L. M., Brown A., Noble M., Sultan S., Provenzale D., The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program. Gastroenterology 2005 129 2 429 436 2-s2.0-23244451080 10.1016/j.gastro.2005.05.055 (Pubitemid 41096631)
37. Shaheen N. J., Dulai G. S., Ascher B., Mitchell K. L., Schmitz S. M., Effect of a new diagnosis of Barrett's esophagus on insurance status. American Journal of Gastroenterology 2005 100 3 577 580 2-s2.0-16844371860 10.1111/j.1572-0241.2005.41422.x (Pubitemid 40487555)
38. Sharma P., Morales T. G., Sampliner R. E., Short segment Barrett's esophagusthe need for standardization of the definition and of endoscopic criteria. American Journal of Gastroenterology 1998 93 7 1033 1036 2-s2.0-0032464684 10.1016/S0002-9270(98)00205-6 (Pubitemid 29080945)
39. Vahabzadeh B., Seetharam A. B., Cook M. B., Validation of the Prague C & M criteria for the endoscopic grading of Barrett's esophagus by gastroenterology trainees: a multicenter study. Gastrointestinal Endoscopy 2012 75 2 236 241
40. Kinjo T., Kusano C., Oda I., Gotoda T., Prague C&M and Japanese criteria: shades of Barrett's esophagus endoscopic diagnosis. Journal of Gastroenterology 2010 45 10 1039 1044 2-s2.0-78249277119 10.1007/s00535-010- 0264-y
41. Alcedo J., Ferrandez A., Arenas J., Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance. Diseases of the Esophagus 2009 22 3 239 248
42. Boyer J., Laugier R., Chemall M., Arpurt J. P., Boustière C., Canard J. M., Dalbies P. A., Gay G., Escourrou J., Napoléon B., Palazzo L., Ponchon T., Richard-Mollard B., Sautereau D., Tucat G., Vedrenne B., French society of digestive endoscopy SFED guideline: monitoring of patients with Barrett's esophagus. Endoscopy 2007 39 9 840 842 2-s2.0-34548165593 10.1055/s-2007-966653 (Pubitemid 47386837)
43. Sharma P., Falk G. W., Weston A. P., Reker D., Johnston M., Sampliner R. E., Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clinical Gastroenterology and Hepatology 2006 4 5 566 572 (Pubitemid 44308164)
44. Lim C. H., Treanor D., Dixon M. F., Axon A. T. R., Low-grade dysplasia in Barrett's esophagus has a high risk of progression. Endoscopy 2007 39 7 581 587 2-s2.0-34547105293 10.1055/s-2007-966592 (Pubitemid 47098993)
45. Schouten L. J., Steevens J., Huysentruyt C. J., Total cancer incidence and overall mortality are not increased among patients with Barrett's esophagus. Clinical Gastroenterology and Hepatology 2011 9 9 754 761
46. Curvers W. L., Ten Kate F. J., Krishnadath K. K., Visser M., Elzer B., Baak L. C., Bohmer C., Mallant-Hent R. C., Van Oijen A., Naber A. H., Scholten P., Busch O. R., Blaauwgeers H. G. T., Meijer G. A., Bergman J. J. G. H. M., Low-grade dysplasia in barrett's esophagus: overdiagnosed and underestimated. American Journal of Gastroenterology 2010 105 7 1523 1530 2-s2.0-77954424898 10.1038/ajg.2010.171
47. Schnell T. G., Sontag S. J., Chejfec G., Aranha G., Metz A., O'Connell S., Seidel U. J., Sonnenberg A., Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001 120 7 1607 1619 2-s2.0-0034995578 (Pubitemid 32523480)
48. Weston A.P., Sharma P., Topalovski M., Richards R., Cherian R., Dixon A., Long-term follow-up of Barrett's high-grade dysplasia. The American Journal of Gastroenterology 2000 95 8 1888 1893
49. Rastogi A., Puli S., El-Serag H. B., Bansal A., Wani S., Sharma P., Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointestinal Endoscopy 2008 67 3 394 398 (Pubitemid 351260043)
50. Hirota W. K., Zuckerman M. J., Adler D. G., ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointestinal Endoscopy 2006 63 4 570 580
51. Abrams J. A., Fields S., Lightdale C. J., Neugut A. I., Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy. Clinical Gastroenterology and Hepatology 2008 6 1 30 34 2-s2.0-37449021270 10.1016/j.cgh.2007.10.006 (Pubitemid 50008419)
52. Edelstein Z. R., Bronner M. P., Rosen S. N., Vaughan T. L., Risk factors for barrett's esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study. American Journal of Gastroenterology 2009 104 4 834 842 2-s2.0-65449181647 10.1038/ajg.2009.137
53. Yachimski P., Lee R. A., Tramontano A., Nishioka N. S., Hur C., Secular trends in patients diagnosed with Barrett's esophagus. Digestive Diseases and Sciences 2010 55 4 960 966 2-s2.0-77950353083 10.1007/s10620-009-0985-z
54. Corley D. A., Kubo A., Levin T. R., Block G., Habel L., Rumore G., Quesenberry C., Buffler P., Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 19942006. Gut 2009 58 2 182 188 2-s2.0-58849148601 10.1136/gut.2008.163360
55. Eloubeidi M. A., Provenzale D., Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans. Journal of Clinical Gastroenterology 2001 33 4 306 309 2-s2.0-0034833925 10.1097/00004836-200110000-00010 (Pubitemid 32880970)
56. Eisen G. M., Sandler R. S., Murray S., Gottfried M., The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. American Journal of Gastroenterology 1997 92 1 27 31 2-s2.0-0031021615 (Pubitemid 27027023)
57. Avidan B., Sonnenberg A., Schnell T. G., Sontag S. J., Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus. Digestive Diseases and Sciences 2002 47 2 256 264 2-s2.0-0036164094 10.1023/A:1013797417170 (Pubitemid 34123982)
58. Edelstein Z. R., Farrow D. C., Bronner M. P., Rosen S. N., Vaughan T. L., Central adiposity and risk of Barrett's esophagus. Gastroenterology 2007 133 2 403 411 2-s2.0-34547518829 10.1053/j.gastro.2007.05.026 (Pubitemid 47187351)
59. El-Serag H. B., Kvapil P., Hacken-Bitar J., Kramer J. R., Abdominal obesity and the risk of Barrett's esophagus. American Journal of Gastroenterology 2005 100 10 2151 2156 2-s2.0-27744517058 10.1111/j.1572-0241. 2005.00251.x
60. Kamat P., Wen S., Morris J., Anandasabapathy S., Exploring the association between elevated body mass index and Barrett's esophagus: a systematic review and meta-analysis. Annals of Thoracic Surgery 2009 87 2 655 662 2-s2.0-58249135670 10.1016/j.athoracsur.2008.08.003
61. Corley D. A., Kubo A., Levin T. R., Block G., Habel L., Zhao W., Leighton P., Quesenberry C., Rumore G. J., Buffler P. A., Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 2007 133 1 34 41 2-s2.0-34447097514 10.1053/j.gastro.2007.04.046 (Pubitemid 47031134)
62. Anderson L. A., Cantwell M. M., Watson R. G. P., Johnston B. T., Murphy S. J., Ferguson H. R., McGuigan J., Comber H., Reynolds J. V., Murray L. J., The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Gastroenterology 2009 136 3 799 805 2-s2.0-60449099583 10.1053/j.gastro.2008.12.005
63. Kubo A., Levin T. R., Block G., Rumore G. J., Quesenberry C. P., Buffler P., Corley D. A., Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. Gastroenterology 2009 136 3 806 815 2-s2.0-60449083716 10.1053/j.gastro.2008.11.042
64. Kubo A., Levin T. R., Block G., Rumore G. J., Quesenberry C. P., Buffler P., Corley D. A., Dietary antioxidants, fruits, and vegetables and the risk of barrett's esophagus. American Journal of Gastroenterology 2008 103 7 1614 1624 2-s2.0-50649085028 10.1111/j.1572-0241.2008.01838.x
65. Kubo A., Levin T. R., Block G., Rumore G. J., Quesenberry C. P., Buffler P., Corley D. A., Dietary patterns and the risk of Barrett's esophagus. American Journal of Epidemiology 2008 167 7 839 846 2-s2.0-41349097283 10.1093/aje/kwm381 (Pubitemid 351451748)
66. Thompson O. M., Beresford S. A. A., Kirk E. A., Vaughan T. L., Vegetable and fruit intakes and risk of Barrett's esophagus in men and women. American Journal of Clinical Nutrition 2009 89 3 890 896 2-s2.0-61449188306 10.3945/ajcn.2008.26497
67. Rokkas T., Pistiolas D., Sechopoulos P., Robotis I., Margantinis G., Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clinical Gastroenterology and Hepatology 2007 5 12 1413 1417
68. Cameron A. J., Zinsmeister A. R., Ballard D. J., Carney J. A., Prevalence of columnar-lined (Barrett's) esophagus: comparison of population-based clinical and autopsy findings. Gastroenterology 1990 99 4 918 922 2-s2.0-0025048626 (Pubitemid 20338445)
69. Musana A. K., Resnick J. M., Torbey C. F., Mukesh B. N., Greenlee R. T., Barrett's esophagus: incidence and prevalence estimates in a rural mid-western population. American Journal of Gastroenterology 2008 103 3 516 524 2-s2.0-40949121063 10.1111/j.1572-0241.2007.01599.x (Pubitemid 351405967)
70. Ronkainen J., Aro P., Storskrubb T., Johansson S. E., Lind T., Bolling-Sternevald E., Graffner H., Vieth M., Stolte M., Engstrand L., Talley N. J., Agréus L., High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scandinavian Journal of Gastroenterology 2005 40 3 275 285 2-s2.0-20144389772 10.1080/00365520510011579 (Pubitemid 40476458)
71. Sharma P., Clinical practice. Barrett's esophagus. The New England Journal of Medicine 2009 361 26 2548 2556
72. Spechler S. J., Clinical practice. Barrett's esophagus. The New England Journal of Medicine 2002 346 11 836 842
73. Glickman J. N., Chen Y. Y., Wang H. H., Antonioli D. A., Odze R. D., Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus. American Journal of Surgical Pathology 2001 25 5 569 578 2-s2.0-0035002904 10.1097/00000478-200105000-00002 (Pubitemid 32423353)
74. Jankowski J. A., Wright N. A., Meltzer S. J., Triadafilopoulos G., Geboes K., Casson A. G., Kerr D., Young L. S., Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. American Journal of Pathology 1999 154 4 965 973 2-s2.0-0032954422 (Pubitemid 29169728)
75. Pera M., Pera M., Experimental Barrett's esophagus and the origin of intestinal metaplasia. Chest Surgery Clinics of North America 2002 12 1 25 37 2-s2.0-0036185213 10.1016/S1052-3359(03)00063-2 (Pubitemid 34214179)
76. Sarosi G., Brown G., Jaiswal K., Feagins L. A., Lee E., Crook T. W., Souza R. F., Zou Y. S., Shay J. W., Spechler S. J., Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus. Diseases of the Esophagus 2008 21 1 43 50 2-s2.0-38049187779 10.1111/j.1442-2050.2007.00744.x
77. Seery J. P., Stem cells of the oesophageal epithelium. Journal of Cell Science 2002 115 9 1783 1789 2-s2.0-0036558278 (Pubitemid 34567240)
78. Kalabis J., Oyama K., Okawa T., Nakagawa H., Michaylira C. Z., Stairs D. B., Figueiredo J. L., Mahmood U., Diehl J. A., Herlyn M., Rustgi A. K., A subpopulation of mouse esophageal basal cells has properties of stem cells with the capacity for self-renewal and lineage specification. Journal of Clinical Investigation 2008 118 12 3860 3869 2-s2.0-57449088880 10.1172/JCI35012
79. Takahashi K., Yamanaka S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006 126 4 663 676 2-s2.0-33747195353 10.1016/j.cell.2006.07.024 (Pubitemid 44233629)
80. Bass A. J., Watanabe H., Mermel C. H., Yu S., Perner S., Verhaak R. G., Kim S. Y., Wardwell L., Tamayo P., Gat-Viks I., Ramos A. H., Woo M. S., Weir B. A., Getz G., Beroukhim R., O'Kelly M., Dutt A., Rozenblatt-Rosen O., Dziunycz P., Komisarof J., Chirieac L. R., Lafargue C. J., Scheble V., Wilbertz T., Ma C., Rao S., Nakagawa H., Stairs D. B., Lin L., Giordano T. J., Wagner P., Minna J. D., Gazdar A. F., Zhu C. Q., Brose M. S., Cecconello I., Jr U. R., Marie S. K., Dahl O., Shivdasani R. A., Tsao M. S., Rubin M. A., Wong K. K., Regev A., Hahn W. C., Beer D. G., Rustgi A. K., Meyerson M., SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nature Genetics 2009 41 11 1238 1242 2-s2.0-70350641014 10.1038/ng.465
81. Stairs D. B., Nakagawa H., Klein-Szanto A., Mitchell S. D., Silberg D. G., Tobias J. W., Lynch J. P., Rustgi A. K., Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus. PLoS ONE 2008 3 10 2-s2.0-55849117334 10.1371/journal.pone.0003534 e3534
82. Kazumori H., Ishihara S., Takahashi Y., Amano Y., Kinoshita Y., Roles of Krüppel-like factor 4 in oesophageal epithelial cells in Barrett's epithelium development. Gut 2011 60 5 608 617 2-s2.0-79953753718 10.1136/gut.2010.221648
83. Vaezi M. F., Richter J. E., Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996 111 5 1192 1199 2-s2.0-0029811274 10.1053/gast.1996.v111.pm8898632 (Pubitemid 26362243)
84. Westhoff B., Brotze S., Weston A., McElhinney C., Cherian R., Mayo M. S., Smith H. J., Sharma P., The frequency of Barrett's esophagus in high-risk patients with chronic GERD. Gastrointestinal Endoscopy 2005 61 2 226 231 2-s2.0-13844313385 10.1016/S0016-5107(04)02589-1 (Pubitemid 40261070)
85. Chen X., Yang G. Y., Ding W. Y., Bondoc F., Curtis S. K., Yang C. S., An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload. Carcinogenesis 1999 20 9 1801 1808 2-s2.0-0032823595 10.1093/carcin/20.9.1801 (Pubitemid 29410561)
86. Goldstein S. R., Yang G. Y., Curtis S. K., Reuhl K. R., Liu B. C., Mirvish S. S., Newmark H. L., Yang C. S., Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 1997 18 11 2265 2270 2-s2.0-0031418208 10.1093/carcin/18.11.2265 (Pubitemid 28134757)
87. Seto Y., Kobori O., Role of reflux oesophagitis and acid in the development of columnar epithelium in the rat oesophagus. British Journal of Surgery 1993 80 4 467 470 2-s2.0-0027394782 (Pubitemid 23116086)
88. Orlando R. C., Pathophysiology of gastroesophageal reflux disease. Journal of Clinical Gastroenterology 2008 42 5 584 588 2-s2.0-42449116248 10.1097/MCG.0b013e31815d0628 (Pubitemid 351572264)
89. Moons L. M. G., Kusters J. G., Bultman E., Kuipers E. J., van Dekken H., Tra W. M. W., Kleinjan A., Kwekkeboom J., van Vliet A. H. M., Siersema P. D., Barrett's oesophagus is characterized by a predominantly humoral inflammatory response. Journal of Pathology 2005 207 3 269 276 2-s2.0-27644452325 10.1002/path.1847 (Pubitemid 41556450)
90. Clark C. E., Hingorani S. R., Mick R., Combs C., Tuveson D. A., Vonderheide R. H., Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Research 2007 67 19 9518 9527 2-s2.0-35148814410 10.1158/0008-5472.CAN-07-0175 (Pubitemid 47535942)
91. De Visser K. E., Korets L. V., Coussens L. M., De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 2005 7 5 411 423 2-s2.0-19344365408 10.1016/j.ccr.2005.04.014 (Pubitemid 40719125)
92. + T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009 16 2 91 102 2-s2.0-67651160649 10.1016/j.ccr.2009.06.018
93. Yang L., DeBusk L. M., Fukuda K., Fingleton B., Green-Jarvis B., Shyr Y., Matrisian L. M., Carbone D. P., Lin P. C., Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 2004 6 4 409 421 2-s2.0-5444225991 10.1016/j.ccr.2004.08.031 (Pubitemid 39361441)
94. Yang L., Huang J., Ren X., Gorska A. E., Chytil A., Aakre M., Carbone D. P., Matrisian L., Richmond A., Lin P. C., Moses H. L., Abrogation of TGF β signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 2008 13 1 23 35 2-s2.0-37349100945 10.1016/j.ccr.2007. 12.004 (Pubitemid 350309741)
95. Morris C. D., Armstrong G. R., Bigley G., Green H., Attwood S. E. A., Cyclooxygenase-2 expression in the barrett's metaplasia-dysplasia-adenocarcinoma sequence. American Journal of Gastroenterology 2001 96 4 990 996 2-s2.0-0035045145 10.1016/S0002-9270(00)02392-3 (Pubitemid 32319127)
96. Duan L., Wu A. H., Sullivan-Halley J., Bernstein L., Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County. Cancer Epidemiology Biomarkers and Prevention 2008 17 1 126 134 2-s2.0-38849157724 10.1158/1055-9965.EPI-07-0664 (Pubitemid 351196282)
97. Sadeghi S., Bain C. J., Pandeya N., Webb P. M., Green A. C., Whiteman D. C., Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus. Cancer Epidemiology Biomarkers and Prevention 2008 17 5 1169 1178 2-s2.0-52649086351 10.1158/1055-9965.EPI-07-2852
98. Kazumori H., Ishihara S., Rumi M. A. K., Kadowaki Y., Kinoshita Y., Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium. Gut 2006 55 1 16 25 2-s2.0-29244432794 10.1136/gut.2005.066209 (Pubitemid 41820630)
99. Wong N. A. C. S., Wilding J., Bartlett S., Liu Y., Warren B. F., Piris J., Maynard N., Marshall R., Bodmer W. F., CDX1 is an important molecular mediator of Barrett's metaplasia. Proceedings of the National Academy of Sciences of the United States of America 2005 102 21 7565 7570 2-s2.0-19644370204 10.1073/pnas.0502031102 (Pubitemid 40741011)
100. Barrett M. T., Yeung K. Y., Ruzzo W. L., Hsu L., Blount P. L., Sullivan R., Zarbl H., Delrow J., Rabinovitch P. S., Reid B. J., Transcriptional analyses of Barrett's metaplasia and normal upper GI mucosae. Neoplasia 2002 4 2 121 128 2-s2.0-0036122474 10.1038/sj/neo/7900221 (Pubitemid 34218680)
101. El-Serag H. B., Nurgalieva Z., Souza R. F., Shaw C., Darlington G., Is genomic evaluation feasible in endoscopic studies of Barrett's esophagus? A pilot study. Gastrointestinal Endoscopy 2006 64 1 17 26 2-s2.0-33745262906 10.1016/j.gie.2005.08.041 (Pubitemid 43949378)
102. Fox C. A., Sapinoso L. M., Zhang H., Zhang W., McLeod H. L., Petroni G. R., Mullick T., Moskaluk C. A., Frierson H. F., Hampton G. M., Powell S. M., Altered expression of TFF-1 and CES-2 in Barrett's esophagus and associated adenocarcinomas. Neoplasia 2005 7 4 407 416 2-s2.0-20844438006 10.1593/neo.04715 (Pubitemid 40664230)
103. Helm J., Enkemann S. A., Coppola D., Barthel J. S., Kelley S. T., Yeatman T. J., Dedifferentiation precedes invasion in the progression from barrett's metaplasia to esophageal adenocarcinoma. Clinical Cancer Research 2005 11 7 2478 2485 2-s2.0-17644416753 10.1158/1078-0432.CCR-04-1280 (Pubitemid 40569443)
104. Kimchi E. T., Posner M. C., Park J. O., Darga T. E., Kocherginsky M., Karrison T., Hart J., Smith K. D., Mezhir J. J., Weichselbaum R. R., Khodarev N. N., Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Research 2005 65 8 3146 3154 2-s2.0-20244365649 (Pubitemid 40524595)
105. Lao-Sirieix P., Boussioutas A., Kadri S. R., O'Donovan M., Debiram I., Das M., Harihar L., Fitzgerald R. C., Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic. Gut 2009 58 11 1451 1459 2-s2.0-70350223628 10.1136/gut.2009.180281
106. Wang S., Zhan M., Yin J., Abraham J. M., Mori Y., Sato F., Xu Y., Olaru A., Berki A. T., Li H., Schulmann K., Kan T., Hamilton J. P., Paun B., Yu M. M., Jin Z., Cheng Y., Ito T., Mantzur C., Greenwald B. D., Meltzer S. J., Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis. Oncogene 2006 25 23 3346 3356 2-s2.0-33744947841 10.1038/sj.onc.1209357 (Pubitemid 43846319)
107. Pepe M. S., Etzioni R., Feng Z., Potter J. D., Thompson M. L., Thornquist M., Winget M., Yasui Y., Phases of biomarker development for early detection of cancer. Journal of the National Cancer Institute 2001 93 14 1054 1061 2-s2.0-0035908491 (Pubitemid 32717537)
108. Chang C. L., Lao-Sirieix P., Save V., Mendez G. D. L. C., Laskey R., Fitzgerald R. C., Retinoic acid-induced glandular differentiation of the oesophagus. Gut 2007 56 7 906 917 2-s2.0-34347237666 10.1136/gut.2006.097915 (Pubitemid 46999073)
109. Ioannides A. S., Henderson D. J., Spitz L., Copp A. J., Role of Sonic hedgehog in the development of the trachea and oesophagus. Journal of Pediatric Surgery 2003 38 1 29 36 2-s2.0-0037242416 10.1053/jpsu.2003.50005 (Pubitemid 36109882)
110. Litingtung Y., Lei L., Westphal H., Chiang C., Sonic hedgehog is essential to foregut development. Nature Genetics 1998 20 1 58 61 2-s2.0-0031711075 10.1038/1717 (Pubitemid 28410345)
111. Wang D. H., Clemons N. J., Miyashita T., Dupuy A. J., Zhang W., Szczepny A., Corcoran-Schwartz I. M., Wilburn D. L., Montgomery E. A., Wang J. S., Jenkins N. A., Copeland N. A., Harmon J. W., Phillips W. A., Watkins D. N., Aberrant epithelial-mesenchymal hedgehog signaling characterizes Barrett's metaplasia. Gastroenterology 2010 138 5 1810 1822 2-s2.0-77951684109 10.1053/j.gastro.2010.01.048
112. Que J., Choi M., Ziel J. W., Klingensmith J., Hogan B. L. M., Morphogenesis of the trachea and esophagus: current players and new roles for noggin and Bmps. Differentiation 2006 74 7 422 437 2-s2.0-33747065208 10.1111/j.1432-0436.2006.00096.x (Pubitemid 44215412)
113. Tselepis C., Perry I., Dawson C., Hardy R., Darnton S. J., McConkey C., Stuart R. C., Wright N., Harrison R., Jankowski J. A. Z., Tumour necrosis factor- α in Barrett's oesophagus: a potential novel mechanism of action. Oncogene 2002 21 39 6071 6081 2-s2.0-18544367202 10.1038/sj.onc.1205731
114. Takubo K., Vieth M., Aida J., Differences in the definitions used for esophageal and gastric diseases in different countries: endoscopic definition of the esophagogastric junction, the precursor of Barrett's adenocarcinoma, the definition of Barrett's esophagus, and histologic criteria for mucosal adenocarcinoma or high-grade dysplasia. Digestion 2009 80 4 248 257
115. Batts K. P., Barrett esophagusmore steps forward. Human Pathology 2001 32 4 357 359 2-s2.0-0035029443 10.1053/hupa.2001.24685 (Pubitemid 32378296)
116. Ruol A., Parenti A., Zaninotto G., Intestinal metaplasia is the probable common precursor of adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia. Cancer 2000 88 11 2520 2528 (Pubitemid 30331958)
117. Gatenby P. A. C., Ramus J. R., Caygill C. P. J., Shepherd N. A., Watson A., Relevance of the detection of intestinal metaplasia in non-dysplastic columnar-lined oesophagus. Scandinavian Journal of Gastroenterology 2008 43 5 524 530 2-s2.0-42149084982 10.1080/00365520701879831 (Pubitemid 351536041)
118. DeMeester S. R., Letter to the editor regarding "Definition of Barrett's esophagus: time for a rethink-is intestinal metaplasia dead?". The American Journal of Gastroenterology 2010 105 5 1201 1203
119. Glickman J. N., Spechler S. J., Souza R. F., Lunsford T., Lee E., Odze R. D., Multilayered epithelium in mucosal biopsy specimens from the gastroesophageal junction region is a histologic marker of gastroesophageal reflux disease. American Journal of Surgical Pathology 2009 33 6 818 825 2-s2.0-67549151029 10.1097/PAS.0b013e3181984697
120. Sharma P., Weston A. P., Morales T., Topalovski M., Mayo M. S., Sampliner R. E., Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut 2000 46 1 9 13 2-s2.0-0034024282 10.1136/gut.46.1.9 (Pubitemid 30307669)
121. Zhu W., Appelman H. D., Greenson J. K., Ramsburgh S. R., Orringer M. B., Chang A. C., McKenna B. J., A histologically defined subset of high-grade dysplasia in Barrett mucosa is predictive of associated carcinoma. American Journal of Clinical Pathology 2009 132 1 94 100 2-s2.0-67650432955 10.1309/AJCP78CKIOJWOVFN
122. Lomo L. C., Blount P. L., Sanchez C. A., Li X., Galipeau P. C., Cowan D. S., Ayub K., Rabinovitch P. S., Reid B. J., Odze R. D., Crypt dysplasia with
123. Park D. Y., Srivastava A., Kim G. H., Mino-Kenudson M., Deshpande V., Zukerberg L. R., Song G. A., Lauwers G. Y., Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia. American Journal of Surgical Pathology 2008 32 4 524 533 2-s2.0-41449111592 10.1097/PAS.0b013e31815b890e (Pubitemid 351458294)
124. Srivastava A., Lauwers G. Y., Gastric epithelial dysplasia: the Western perspective. Digestive and Liver Disease 2008 40 8 641 649 2-s2.0-44949224229 10.1016/j.dld.2008.02.039
125. Mahajan D., Bennett A. E., Liu X., Bena J., Bronner M. P., Grading of gastric foveolar-type dysplasia in Barrett's esophagus. Modern Pathology 2010 23 1 1 11 2-s2.0-73949135640 10.1038/modpathol.2009.147
126. Kerkhof M., Van Dekken H., Steyerberg E. W., Meijer G. A., Mulder A. H., De Bruïne A., Driessen A., Ten Kate F. J., Kusters J. G., Kuipers E. J., Siersema P. D., Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology 2007 50 7 920 927 2-s2.0-34249815173 10.1111/j.1365-2559.2007. 02706.x (Pubitemid 46850080)
127. Downs-Kelly E., Mendelin J. E., Bennett A. E., Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies. The American Journal of Gastroenterology 2008 103 9 2333 2341
128. Montgomery E., Bronner M. P., Goldblum J. R., Greenson J. K., Haber M. M., Hart J., Lamps L. W., Lauwers G. Y., Lazenby A. J., Lewin D. N., Robert M. E., Toledano A. Y., Shyr Y., Washington K., Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Human Pathology 2001 32 4 368 378 2-s2.0-0035028767 10.1053/hupa.2001.23510 (Pubitemid 32378298)
129. Montgomery E., Goldblum J. R., Greenson J. K., Haber M. M., Lamps L. W., Lauwers G. Y., Lazenby A. J., Lewin D. N., Robert M. E., Washington K., Zahurak M. L., Hart J., Dysplasia as a predictive marker for invasive carcinoma in barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Human Pathology 2001 32 4 379 388 2-s2.0-0035034648 10.1053/hupa.2001.23511 (Pubitemid 32378299)
130. Coco D. P., Goldblum J. R., Hornick J. L., Lauwers G. Y., Montgomery E., Srivastava A., Wang H., Odze R. D., Interobserver variability in the diagnosis of crypt dysplasia in barrett esophagus. American Journal of Surgical Pathology 2011 35 1 45 54 2-s2.0-78650863600 10.1097/PAS.0b013e3181ffdd14
131. Goldblum J. R., Controversies in the diagnosis of Barrett esophagus and Barrett-related dysplasia. Archives of Pathology and Laboratory Medicine 2010 134 10 1479 1484 2-s2.0-78650428299
132. Kaye P. V., Haider S. A., Ilyas M., James P. D., Soomro I., Faisal W., Catton J., Parsons S. L., Ragunath K., Barrett's dysplasia and the Vienna classification: reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistry. Histopathology 2009 54 6 699 712 2-s2.0-65349095555 10.1111/j.1365-2559.2009.03288.x
133. Lörinc E., Jakobsson B., Landberg G., Veress B., Ki67 and p53 immunohistochemistry reduces interobserver variation in assessment of Barrett's oesophagus. Histopathology 2005 46 6 642 648 2-s2.0-20644458561 10.1111/j.1365-2559.2005.02139.x (Pubitemid 40834823)
134. Binato M., Gurski R. R., Fagundes R. B., Meurer L., Edelweiss M. I., P53 and Ki-67 overexpression in gastroesophageal reflux disease-Barrett's esophagus and adenocarcinoma sequence. Diseases of the Esophagus 2009 22 7 588 595 2-s2.0-73949099910
135. Van Dekken H., Hop W. C. J., Tilanus H. W., Haringsma J., Van Der Valk H., Wink J. C., Vissers K. J., Immunohistochemical evaluation of a panel of tumor cell markers during malignant progression in Barrett esophagus. American Journal of Clinical Pathology 2008 130 5 745 753 2-s2.0-55249090166 10.1309/AJCPO31THGVEUIDH
136. Robertson C. S., Mayberry J. F., Nicholson D. A., James P. D., Atkinson M., Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. British Journal of Surgery 1988 75 8 760 763 2-s2.0-0023686651
137. Reid B. J., Blount P. L., Rubin C. E., Levine D. S., Haggitt R. C., Rabinovitch P. S., Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992 102 4 1212 1219 2-s2.0-0026518795
138. Bartlesman J. F., Hameeteman W., Ttgat G. N., Barrett's oesophagus. European Journal of Cancer Prevention 1992 1 4 323 325 2-s2.0-0026879459
139. Shaheen N. J., Crosby M. A., Bozymski E. M., Sandler R. S., Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000 119 2 333 338 2-s2.0-0033866197 (Pubitemid 30621983)
140. Clark G. W. B., Smyrk T. C., Burdiles P., Hoeft S. F., Peters J. H., Kiyabu M., Hinder R. A., Bremner C. G., DeMeester T. R., Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Archives of Surgery 1994 129 6 609 614 2-s2.0-0028365812 (Pubitemid 24179204)
141. Headrick J. R., Nichols F. C. III, Miller D. L., High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. The Annals of Thoracic Surgery 2002 73 6 1697 1702
142. Overholt B. F., Lightdale C. J., Wang K. K., Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointestinal Endoscopy 2005 62 4 488 498 (Pubitemid 41383764)
143. Reid B. J., Levine D. S., Longton G., Blount P. L., Rabinovitch P. S., Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. American Journal of Gastroenterology 2000 95 7 1669 1676 2-s2.0-0033915683 10.1016/S0002- 9270(00)00988-6 (Pubitemid 30485000)
144. Buttar N. S., Wang K. K., Sebo T. J., Riehle D. M., Krishnadath K. K., Lutzke L. S., Anderson M. A., Petterson T. M., Burgart L. J., Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001 120 7 1630 1639 2-s2.0-0035022127 (Pubitemid 32523482)
145. Locke G. R. III, Talley N. J., Fett S. L., Zinsmeister A. R., Melton L. J., Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997 112 5 1448 1456 2-s2.0-0030931230 (Pubitemid 27181367)
146. Anderson L. A., Murray L. J., Murphy S. J., Fitzpatrick D. A., Johnston B. T., Watson R. G. P., McCarron P., Gavin A. T., Mortality in Barrett's oesophagus: results from a population based study. Gut 2003 52 8 1081 1084 2-s2.0-0038637416 10.1136/gut.52.8.1081 (Pubitemid 36877416)
147. Oude Rengerink K., Opmeer B. C., Logtenberg S. L. M., Hooft L., Bloemenkamp K. W. M., Haak M. C., Oudijk M. A., Spaanderman M. E., Duvekot J. J., Willekes C., Van Pampus M. G., Porath M. M., Van Eyck J., Sikkema M. J., Mol B. W. J., IMproving participation of patients in clinical trialsrationale and design of IMPACT. BMC Medical Research Methodology 2010 10, article 85 2-s2.0-77957114896 10.1186/1471-2288-10-85
148. Streitz J. M. Jr., Andrews C. W., Ellis F. H., Skinner D. B., Trastek V. F., Benfield J. R., Endoscopic surveillance of Barrett's esophagus: does it help? Journal of Thoracic and Cardiovascular Surgery 1993 105 3 383 388 2-s2.0-0027528844 (Pubitemid 23097616)
149. Peters J. H., Clark G. W. B., Ireland A. P., Chandrasoma P., Smyrk T. C., DeMeester T. R., Ellis F. H., Rusch V. W., Warren W. H., Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. Journal of Thoracic and Cardiovascular Surgery 1994 108 5 813 822 2-s2.0-0028027451 (Pubitemid 24351664)
150. Fountoulakis A., Zafirellls K. D., Dolan K., Dexter S. P. L., Martin I. G., Sue-Ling H. M., Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer. British Journal of Surgery 2004 91 8 997 1003 2-s2.0-4043109112 10.1002/bjs.4591 (Pubitemid 39070814)
151. Corley D. A., Levin T. R., Habel L. A., Weiss N. S., Buffler P. A., Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 2002 122 3 633 640 2-s2.0-0036179390 (Pubitemid 34173814)
152. Van Sandick J. W., Van Lanschot J. J. B., Kuiken B. W., Tytgat G. N. J., Offerhaus G. J. A., Obertop H., Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998 43 2 216 222 2-s2.0-0031855413 (Pubitemid 28348324)
153. Dulai G. S., Guha S., Kahn K. L., Gornbein J., Weinstein W. M., Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology 2002 122 1 26 33 2-s2.0-0036143976 (Pubitemid 34049191)
154. Bytzer P., Christensen P. B., Damkier P., Vinding K., Seersholm N., Adenocarcinoma of the esophagus and Barrett's esophagus: a population- based study. American Journal of Gastroenterology 1999 94 1 86 91 2-s2.0-0032893795 10.1111/j.1572-0241.1999.00776.x (Pubitemid 29063449)
155. Fitzgerald R. C., Saeed I. T., Khoo D., Farthing M. J. G., Burnham W. R., Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus. Digestive Diseases and Sciences 2001 46 9 1892 1898 2-s2.0-0034855860 10.1023/A:1010678913481 (Pubitemid 32844155)
156. Abrams J. A., Kapel R. C., Lindberg G. M., Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States. Clinical Gastroenterology and Hepatology 2009 7 7 736 742
157. Curvers W. L., Peters F. P., Elzer B., Schaap A. J. C. M., Baak L. C., Oijen A. V., Mallant-Hent R. M., Kate F. T., Krishnadath K. K., Bergman J. J. G. H. M., Quality of Barrett's surveillance in The Netherlands: a standardized review of endoscopy and pathology reports. European Journal of Gastroenterology and Hepatology 2008 20 7 601 607 2-s2.0-62149111557 10.1097/MEG.0b013e3282f8295d
158. Williamson W. A., Ellis F. H. Jr., Gibb S. P., Shahian D. M., Aretz H. T., Effect of antireflux operation on Barrett's mucosa. Annals of Thoracic Surgery 1990 49 4 537 542 2-s2.0-0025303860 (Pubitemid 20149252)
159. Wani S., Sayana H., Sharma P., Endoscopic eradication of Barrett's esophagus. Gastrointestinal Endoscopy 2010 71 1 147 166
160. Wani S., Mathur S., Sharma P., How to manage a Barrett's esophagus patient with low-grade dysplasia. Clinical Gastroenterology and Hepatology 2009 7 1 27 32
161. Shaheen N. J., Frantz D. J., When to consider endoscopic ablation therapy for Barrett's esophagus. Current Opinion in Gastroenterology 2010 26 4 361 366 2-s2.0-77954142407 10.1097/MOG.0b013e32833ad543
162. Das A., Wells C., Kim H. J., Fleischer D. E., Crowell M. D., Sharma V. K., An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus. Endoscopy 2009 41 5 400 408 2-s2.0-67849108418 10.1055/s-0029-1214612
163. Shaheen N. J., Sharma P., Overholt B. F., Wolfsen H. C., Sampliner R. E., Wang K. K., Galanko J. A., Bronner M. P., Goldblum J. R., Bennett A. E., Jobe B. A., Eisen G. M., Fennerty M. B., Hunter J. G., Fleischer D. E., Sharma V. K., Hawes R. H., Hoffman B. J., Rothstein R. I., Gordon S. R., Mashimo H., Chang K. J., Muthusamy V. R., Edmundowicz S. A., Spechler S. J., Siddiqui A. A., Souza R. F., Infantolino A., Falk G. W., Kimmey M. B., Madanick R. D., Chak A., Lightdale C. J., Radiofrequency ablation in Barrett's esophagus with dysplasia. New England Journal of Medicine 2009 360 22 2277 2288 2-s2.0-66249084112 10.1056/NEJMoa0808145
164. Heitmiller R. F., Redmond M., Hamilton S. R., Barrett's esophagus with high-grade dysplasia: an indication for prophylactic esophagectomy. Annals of Surgery 1996 224 1 66 71 2-s2.0-0030004350 10.1097/00000658-199607000-00010 (Pubitemid 26227409)
165. Konda V. J., Ross A. S., Ferguson M. K., Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? Clinical Gastroenterology and Hepatology 2008 6 2 159 164
166. Hulscher J. B. F., Van Sandick J. W., De Boer A. G. E. M., Wijnhoven B. P. L., Tijssen J. G. P., Fockens P., Stalmeier P. F. M., Ten Kate F. J. W., Van Dekken H., Obertop H., Tilanus H. W., Lanschot J., Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. New England Journal of Medicine 2002 347 21 1662 1669 2-s2.0-0037153029 10.1056/NEJMoa022343 (Pubitemid 35340784)
167. Prasad G. A., Wang K. K., Buttar N. S., Wongkeesong L. M., Krishnadath K. K., Nichols F. C., Lutzke L. S., Borkenhagen L. S., Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology 2007 132 4 1226 1233 2-s2.0-34247263209 10.1053/j.gastro.2007.02.017 (Pubitemid 46627583)
168. Das A., Singh V., Fleischer D. E., Sharma V. K., A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. American Journal of Gastroenterology 2008 103 6 1340 1345 2-s2.0-44949201413 10.1111/j.1572-0241. 2008.01889.x (Pubitemid 351813937)
169. Larghi A., Lightdale C. J., Memeo L., Bhagat G., Okpara N., Rotterdam H., EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. Gastrointestinal Endoscopy 2005 62 1 16 23 (Pubitemid 40922435)
170. Sayana H., Wani S., Keighley J., Endoscopic mucosal resection (EMR) as a diagnostic tool in Barrett's esophagus (BE) patients with high-grade dysplasia (HGD) and early esophageal adenocarcinoma (EAC): a systemic review. Gastroenterology 2008 134 W1878
171. Seewald S., Akaraviputh T., Seitz U., Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointestinal Endoscopy 2003 57 7 854 859 (Pubitemid 47241100)
172. Peters F. P., Kara M. A., Rosmolen W. D., Ten Kate F. J. W., Krishnadath K. K., Van Lanschot J. J. B., Fockens P., Bergman J. J. G. H. M., Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study. American Journal of Gastroenterology 2006 101 7 1449 1457 2-s2.0-33745574316 10.1111/j.1572-0241. 2006.00635.x (Pubitemid 43980615)
173. Soehendra N., Seewald S., Groth S., Use of modified multiband ligator facilitates circumferential EMR in Barrett's esophagus (with video). Gastrointestinal Endoscopy 2006 63 6 847 852
174. Shaheen N. J., Overholt B. F., Sampliner R. E., Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology 2011 141 2 460 468
175. Overholt B. F., Panjehpour M., Halberg D. L., Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointestinal Endoscopy 2003 58 2 183 188 (Pubitemid 38220265)
176. Fernando H. C., Murthy S. C., Hofstetter W., Shrager J. B., Bridges C., Mitchell J. D., Landreneau R. J., Clough E. R., Watson T. J., The society of thoracic surgeons practice guideline series: guidelines for the management of Barrett's esophagus with high-grade dysplasia. Annals of Thoracic Surgery 2009 87 6 1993 2002 2-s2.0-65849504869 10.1016/j.athoracsur.2009.04.032
177. Clemons N. J., McColl K. E. L., Fitzgerald R. C., Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms. Gastroenterology 2007 133 4 1198 1209 2-s2.0-34848928116 10.1053/j.gastro.2007.06.061 (Pubitemid 47494447)
178. Souza R. F., Shewmake K., Terada L. S., Spechler S. J., Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology 2002 122 2 299 307 2-s2.0-0036161377 (Pubitemid 34126346)
179. El-Serag H. B., Aguirre T. V., Davis S., Kuebeler M., Bhattacharyya A., Sampliner R. E., Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. American Journal of Gastroenterology 2004 99 10 1877 1883 2-s2.0-7044232109 10.1111/j.1572-0241.2004.30228.x (Pubitemid 39421227)
180. Hillman L. C., Chiragakis L., Shadbolt B., Kaye G. L., Clarke A. C., Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus. Medical Journal of Australia 2004 180 8 387 391 2-s2.0-1942500137 (Pubitemid 38528957)
181. Cooper B. T., Chapman W., Neumann C. S., Gearty J. C., Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. Alimentary Pharmacology and Therapeutics 2006 23 6 727 733 2-s2.0-33644781586 10.1111/j.1365-2036.2006. 02825.x (Pubitemid 43344591)
182. Garcia Rodriguez L. A., Lagergren J., Lindblad M., Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut 2006 55 11 1538 1544 (Pubitemid 44629198)
183. Anderson L. A., Johnston B. T., Watson R. G. P., Murphy S. J., Ferguson H. R., Comber H., McGuigan J., Reynolds J. V., Murray L. J., Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia- adenocarcinoma sequence. Cancer Research 2006 66 9 4975 4982 2-s2.0-33646436171 10.1158/0008-5472.CAN-05-4253
184. Souza R. F., Shewmake K., Beer D. G., Cryer B., Spechler S. J., Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Research 2000 60 20 5767 5772 2-s2.0-0034667497
185. Buttar N. S., Wang K. K., Anderson M. A., Dierkhising R. A., Pacifico R. J., Krishnadath K. K., Lutzke L. S., The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study. Journal of the National Cancer Institute 2002 94 6 422 429 2-s2.0-0037139613 (Pubitemid 34285091)
186. Wang D., Dubois R. N., Prostaglandins and cancer. Gut 2006 55 1 115 122 2-s2.0-29244449354 10.1136/gut.2004.047100 (Pubitemid 41820645)
187. Corley D. A., Kerlikowse K., Verma R., Buffler P., Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 2003 124 1 47 56 2-s2.0-0037219463 10.1053/gast.2003.50008 (Pubitemid 36055338)
188. Vaughan T. L., Dong L. M., Blount P. L., Ayub K., Odze R. D., Sanchez C. A., Rabinovitch P. S., Reid B. J., Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. The Lancet Oncology 2005 6 12 945 952 2-s2.0-28044459843 10.1016/S1470-2045(05) 70431-9 (Pubitemid 41685227)
189. Kastelein F., Spaander M. C., Biermann K., Steyerberg E. W., Kuipers E. J., Bruno M. J., Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus. Gastroenterology 2011 141 6 2000 2008
190. Ogunwobi O. O., Beales I. L. P., Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells. American Journal of Gastroenterology 2008 103 4 825 837 2-s2.0-41849115563 10.1111/j.1572-0241.2007. 01773.x (Pubitemid 351501115)
191. Konturek P. C., Burnat G., Hahn E. G., Inhibition of Barret's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins. Journal of Physiology and Pharmacology 2007 58 supplement 3 141 148 (Pubitemid 47523111)
192. Nguyen D. M., Richardson P., El-Serag H. B., Medications (NSAIDs, Statins, Proton Pump Inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology 2010 138 7 2260 2266 2-s2.0-77952837521 10.1053/j.gastro.2010.02.045
193. Kahrilas P. J., The problems with surveillance of Barrett's esophagus. The New England Journal of Medicine 2011 365 15 1437 1438
194. Kadri S. R., Lao-Sirieix P., O'Donovan M., Debiram I., Das M., Blazeby J. M., Emery J., Boussioutas A., Morris H., Walter F. M., Pharoah P., Hardwick R. H., Fitzgerald R. C., Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study. British Medical Journal 2010 341 c4372 2-s2.0-77957035085 10.1136/bmj.c4372
195. Quaroni L., Zhao R., Casson A. G., Shining light on Barrett's esophagus. Expert Review of Gastroenterology and Hepatology 2009 3 6 577 580 2-s2.0-73449099302 10.1586/egh.09.43
196. Dattamajumdar A. K., Blount P. L., Myers J. A., Proctor A. H., Goldman B. H., Reid B. J., Martin R. W., A low-cost fiber-optic instrument to colorimetrically detect patients with Barrett's esophagus for early detection of esophageal adenocarcinoma. IEEE Transactions on Biomedical Engineering 2001 48 6 695 705 2-s2.0-0034981223 10.1109/10.923787 (Pubitemid 32510053)
197. Pohl H., Rösch T., Vieth M., Koch M., Becker V., Anders M., Khalifa A. C., Meining A., Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus. Gut 2008 57 12 1648 1653 2-s2.0-56549107208 10.1136/gut.2008.157461
198. Georgakoudi I., Jacobson B. C., Van Dam J., Backman V., Wallace M. B., Müller M. G., Zhang Q., Badizadegan K., Sun D., Thomas G. A., Perelman L. T., Feld M. S., Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus. Gastroenterology 2001 120 7 1620 1629 2-s2.0-0035010521 (Pubitemid 32523481)
199. Evans J. A., Poneros J. M., Bouma B. E., Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus. Clinical Gastroenterology and Hepatology 2006 4 1 38 43 (Pubitemid 43129522)
200. Wolfsen H. C., Crook J. E., Krishna M., Achem S. R., Devault K. R., Bouras E. P., Loeb D. S., Stark M. E., Woodward T. A., Hemminger L. L., Cayer F. K., Wallace M. B., Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's esophagus. Gastroenterology 2008 135 1 24 31 2-s2.0-46049093777 10.1053/j.gastro.2008.03.019 (Pubitemid 351899007)
201. Ganz R. A., Barrett's esophagus. New England Journal of Medicine 2010 362 15 1448 1449 2-s2.0-77950980857 10.1056/NEJMc1001965